Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Peripheral intravenous catheterization, a common procedure in pediatric emergency and hospital settings, often causes significant anxiety and pain in children and their parents. Pain and fear are closely linked, so managing both effectively is important for the childs well-being. This study evaluates the use of PARO, a therapeutic robot shaped like a baby seal, to help manage pain during this procedure in children aged 12 months to 7 years. The trial compares standard pain management care with and without the addition of the PARO robot. Standard care may include topical anesthesia with EMLA cream applied before the procedure, analgesia using a mixture of oxygen and nitrous oxide MEOPA during the procedure, and non-pharmacological methods like music therapy or watching cartoons. In the experimental group, the PARO robot is introduced about 15 minutes before the procedure to help reduce pain and anxiety. The procedure itself involves skin disinfection, vein identification, needle insertion, and concludes when the needle is removed and dressed. Participants will be assessed for pain using the FLACC scale during the procedure. Secondary measures include distress levels, heart rate variability, number of catheterization attempts, parental anxiety, and satisfaction of parents and healthcare staff. Data collection occurs during and shortly after the procedure, with parental and staff satisfaction assessed 15 minutes post-procedure. The study enrolls 120 children across multiple centers to determine if adding the PARO robot improves pain management during intravenous line placement.
Actively Recruiting
Researchers are studying the care pathways of 300 adult patients diagnosed with anal squamous cell carcinoma to identify barriers and delays in diagnosis. The study aims to assess waiting times for consultations, evaluate potential fast-track diagnostic options, and analyze the role of screening and access to care. It also seeks to understand patient reluctance, socio-economic impacts, and knowledge about the link between HPV and anal cancer to enhance awareness and early diagnosis. Participants will complete a self-administered questionnaire to provide information about their care journey, difficulties encountered, and understanding of HPVs role in anal cancer. The study will analyze how many cancers were diagnosed through screening and how many eligible patients missed screening opportunities. This observational study does not involve treatments but focuses on evaluating diagnostic and care processes. Throughout the study, researchers will collect data on first symptoms and histological diagnosis, tumor staging, health inequalities, HPVs connection to anal cancer, and whether rectal exams were performed at first consultations. This data will help improve public and healthcare professional awareness and support earlier diagnosis. The study is expected to run until the end of 2028, with participant involvement mainly through questionnaire completion and medical record analysis.